CLINICAL AND ECONOMIC OUTCOMES ASSOCIATED WITH TERIPARATIDE ADHERENCE IN MEDICARE PART D RECIPIENTS- A RETROSPECTIVE COHORT STUDY
Author(s)
Hazel-Fernandez L1, Louder A2, Foster S3, Uribe C2, Burge RT31Competitive Health Analytics, Humana, Miramar, FL, USA, 2Competitive Health Analytics, Humana, Louisville, KY, USA, 3Eli Lilly and Company, Inc., Indianapolis, IN, USA
OBJECTIVES: To evaluate the utilization patterns of Medicare Part D beneficiaries newly started on teriparatide and the association of adherence with fracture outcomes and health care utilization. METHODS: A retrospective cohort analysis was performed using medical and pharmacy claims of 761 Humana members aged 18 and older with first prescription fills for teriparatide between January 2008 and December 2009. Low Income Subsidy enrollees were excluded. Descriptive analyses summarized baseline characteristics, healthcare use, and costs at 12 and 24 months post teriparatide initiation. Adherence was measured by Proportion of Days Covered (PDC), categorized as high (PDC ≥80%), intermediate (50%
Conference/Value in Health Info
2012-06, ISPOR 2012, Washington, D.C., USA
Value in Health, Vol. 15, No. 4 (June 2012)
Code
PMS68
Topic
Health Service Delivery & Process of Care
Topic Subcategory
Prescribing Behavior
Disease
Musculoskeletal Disorders
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now